Weakness in the equity market has driven the decline of sell-side coverage by 27
percent. As the sell side shrinks, the buy side is beefing up. The reverberations can be felt throughout the financial community.
How Digital Medicine Can Pinpoint Dosing Regimens to Optimize Drug Efficacy and Safety
Sponsored By Oracle
Multi-faceted Approaches to Meet Payer and Regulatory Evidence Requirements
Sponsored By UBC Express Scripts
Overcoming the Life Sciences Content Conundrum in a Multichannel World
Sponsored By Veeva